|
Reliant Pharmaceuticals was a company purchased by GlaxoSmithKline in December 2007 for $1.65B. Co-founded by Joseph J. Krivulka. It was known for six major products, including ()(Omega-3)], Axid(H2 blocker), Dynacirc CR (calcium channel blocker), Antara (fenofibrate), (XL )] (beta blocker), and Rythmol SR (Class IC anti-arrhythmic). Reliant Pharmaceuticals, Inc. was a pharmaceutical company that specialized in the development, commercialization and marketing of prescription therapeutic products. Reliant marketed six cardiovascular products in the United States and focused on promoting its products to targeted primary care and specialty physicians, as well as selected hospitals and academic centers in the United States. Reliants' sales force consisted of approximately 650 sales and marketing professionals nationwide. ==References== 〔 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「Reliant Pharmaceuticals」の詳細全文を読む スポンサード リンク
|